{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:51:22Z","timestamp":1792788682208,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases","award":["1K08DK143343-01"],"award-info":[{"award-number":["1K08DK143343-01"]}],"id":[{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1681\/asn.0000001118","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:02:02Z","timestamp":1777478522000},"page":"1118-1120","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["New Insights in Fibroblast Growth Factor 23 Pathobiology in Kidney Diseases"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8209-2943","authenticated-orcid":false,"given":"Kyle P.","family":"Jansson","sequence":"first","affiliation":[{"name":"The Jared Grantham Kidney Institute, University of Kansas Medical Center, and Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"10","key":"B1-20261014","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"B2-20261014","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"6","key":"B3-20261014","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med."},{"issue":"9","key":"B4-20261014","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B5-20261014","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Chronic kidney disease biomarkers C. Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B6-20261014","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1681\/ASN.0000000963","article-title":"Systemic phosphate elevations induce fibroblast growth factor 23 production in skeletal muscle to reduce renal phosphate reabsorption in mice","volume":"37","author":"Heitman","year":"2026","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B7-20261014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ki.2013.194","article-title":"Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease","volume":"84","author":"Zhang","year":"2013","journal-title":"Kidney Int."},{"issue":"4","key":"B8-20261014","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"issue":"16","key":"B9-20261014","doi-asserted-by":"crossref","first-page":"e145693","DOI":"10.1172\/JCI145693","article-title":"Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression","volume":"131","author":"Shiizaki","year":"2021","journal-title":"J Clin Invest."},{"issue":"1","key":"B10-20261014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/an.113.004861","article-title":"Assessing the health impact of phosphorus in the food supply: issues and considerations","volume":"5","author":"Calvo","year":"2014","journal-title":"Adv Nutr."},{"issue":"11","key":"B11-20261014","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.0000000873","article-title":"ASN kidney health guidance on potassium and phosphorus food additives","volume":"36","author":"Biruete","year":"2025","journal-title":"J Am Soc Nephrol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:00:43Z","timestamp":1791993643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001118","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}